ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
Position in TAK — Takeda Pharmaceutical Co Ltd
CIK 1164508
BOSTON, MA
Position in TAK
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$59,838,771
+$2,124,692 QoQ
Shares Held
3,732,924
+19.8% QoQ
Ownership
0.117%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#7
of 375 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 70%
Shared 0%
None 30%
Common Shares in TAK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026ARROWSTREET CAPITAL, LIMITED PARTNERSHIP holds $921,160,135 across 28 Drug Manufacturers - Specialty & Generic names. TAK ranks #6 (6.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,137,442 | $225,456,582 | |
| 2 | VTRS |
Viatris Inc
|
8,371,218 | $132,934,941 | |
| 3 | HLN |
Haleon plc
|
14,181,817 | $132,316,352 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
|
1,642,086 | $67,374,788 | |
| 5 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
957,514 | $61,233,020 | |
| 6 | TAK |
Takeda Pharmaceutical Co Ltd
This page
|
3,732,924 | $59,838,771 | |
| 7 | ANIP |
Ani Pharmaceuticals Inc
|
562,016 | $46,523,684 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
1,872,157 | $46,073,783 |
All Filings in TAK
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $59,838,771 | 3,732,924 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $57,714,079 | 3,116,311 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $88,595,584 | 5,682,847 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $41,413,309 | 2,828,778 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $18,840,947 | 1,218,690 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $20,824,780 | 1,400,456 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $55,824,778 | 4,216,373 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $459,015 | 4,635,392 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $29,962,764 | 2,315,515 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $18,958,836 | 1,364,927 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $27,230,313 | 1,908,221 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $38,271,387 | 2,473,910 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $36,670,203 | 2,334,195 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $17,423,892 | 1,057,275 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $60,907,017 | 3,904,296 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $18,665,360 | 1,439,118 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $14,504,527 | 1,033,086 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $2,315,730 | 161,713 | Shares | Defined | 2022-05-13 | |
| 2021-06-30 | $1,475,991 | 87,700 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $4,768,252 | 261,131 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $4,207,439 | 231,178 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $8,023,450 | 449,745 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $9,584,983 | 534,578 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $6,299,715 | 415,001 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||